SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.690-2.8%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AgAuUSA who wrote (11062)11/25/1998 6:08:00 PM
From: AgAuUSA  Read Replies (2) of 14328
 
To any and all concerned,

About the volatility: I believe the traders and MM are playing some kind of "game" to boost their volumes or their profits. The fundamentals of the co, at this time, appear to be supportive of a higher equity price (see below).

Looking out, multiple products are up for approvals which should carry wide market demand. UniGold Strep A and HIV are huge products, with potential for large demand. The recent acquisitions (LpA, etc) should also boost revenues substantially.

Trinity, at this time, should carry a profit margin of about 43% on the range of products it sells. This is extremely bullish for further bottom line growth vs prior margins of the former lead product (EPT test) at 13%.

Future Earnings Expectation:

98 = 0.09
99 = 0.15
00 = 0.20+

Stock Price, Fair Value Estimete:

PE (commonly = growth rate = an extremely conservative 30% for Triby) x earns =
98 @ $2.70
99 @ $4.50
00 @ $6.00

I know their are doubters, fine. To the others, hang in, think it thru, add to your positions into this weakness (if you can) and hold. Continued patience will be rewarded!!!

I anticipate alot of grateful millionaires,

GG
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext